December 2015
Volume 39, No. 12 |
|
|
|
|
|
|Focus|
Rita C. Peters
Bio/pharma employee dissatisfaction with pay and progress may direct some to new career pathways.
read more
|
|
|FORMULATION|
Adeline Siew, PhD
The advantages of fixed-dose combinations are well recognized but their formulation and manufacture can be a challenge, Stefania Barzanti from IMA Active explains why. read more |
|
|PEER-REVIEW RESEARCH|
James Agalloco and James Akers
Microorganism lethality requirements for process validation must always be balanced with the need to protect product integrity and patient safety. read more |
|
|
PharmTech December Issue
advertisement
|
|
|
|
|
|
|REGULATORY WATCH|
Jill Wechsler
FDA confirmed quality focus while Congress moved to bolster biomedical innovation. read more
|
|
|
|SEMISOLIDS QUALITY|
Agnes Shanley
Quality by design, in-vitro release testing, and modern analytical methods are improving understanding and control of these complex formulations.
read more
|
|
|
|ROOM PRESSURIZATION|
Eric Bohn
All openings and potential breaches for air penetration must be considered when designing a cleanroom so that the HVAC system can maintain the desired negative or positive pressure.
read more
|
|
|
|GLOBAL MARKET REPORT|
Michael J. Kuchenreuther, PhD
The author provides an overview of the key aspects of the current Canadian pharmaceutical market.
read more
|
|
|
|API SYNTHESIS & MANUFACTURING|
Cynthia A. Challener
A strong API market is expected in 2016 despite fewer new drug approvals.
read more
|
|
|
|TROUBLESHOOTING|
Jennifer Markarian
Analytical methods and functional assays are used to compare molecules and relate characteristics to quality attributes for determining biosimilarity.
read more
|
|
|
|OUTSOURCING OUTLOOK|
Jim Miller
CMO industry consolidation may be frustrated by a dearth of attractive assets.
read more
|
|
|
|ASK THE EXPERT|
Susan J. Schniepp, Andrew Harrison
Susan Schniepp, distinguished fellow, and Andrew Harrison, chief regulatory affairs officer and general counsel, both of Regulatory Compliance Associates, discuss how to write standard operating procedures that hold up to audits.
read more
|
|
|
|VIEWPOINT|
Rita C. Peters
Employers have work to do to improve job satisfaction and retain qualified workers.
read more
|
|
|
|Webcasts|
On Demand Proper drug release of high-dose hydrophilic drugs is a challenge for formulators since both the initial drug burst release, as well as the consequent sustained release, need to be controlled. Excipients can provide an answer to drug release challenges when their hydrophobic nature is coupled with thermal sintering. This approach intensifies the retardation of drug release by forming plastic matrices of high mechanical strength, which can withstand dose dumping and achieve controlled release. In this webcast, a formulation expert will discuss BASF's Kolliwax grades and their suitability for thermal sintering; describe how high-dose hydrophilic actives were selected to demonstrate the efficacy of thermal sintering (60-65% w/w) using Kolliwax grades; and present processing parameters to enable customers to reproduce controlled drug release of hydrophilic drugs using thermal sintering.
Sponsored by BASF
On Demand Join Tosoh Bioscience and Semba Biosciences for a discussion on the use of high capacity protein A and hydroxyapatite resins for mAb purification using a multi-column continuous chromatography process.
Sponsored by Tosoh Bioscience
more webcasts
|
|
|
|on pharmtech tv|
Tablet Coating
Blow Fill Seal for Aseptic Processing
Cell Therapies
|
|
|
|Events|
February 2, 2016–February 4, 2016 | New Orleans, LA
March 14, 2016–March 16, 2016 | San Antonio, TX
May 23, 2016–May 25, 2016 | Berlin, Germany
more events
|
|
|
|
|